These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7334461)

  • 61. Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.
    Scott-Moncrieff JC; Chan TC; Samuels ML; Cook JR; Coppoc GL; DeNicola DB; Richardson RC
    Cancer Chemother Pharmacol; 1991; 29(1):13-8. PubMed ID: 1742843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics and pharmacodynamics of midazolam in the enflurane-anesthetized dog.
    Hall RI; Szlam F; Hug CC
    J Pharmacokinet Biopharm; 1988 Jun; 16(3):251-62. PubMed ID: 3221325
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disposition and metabolism of the antitumor glycoside phyllanthoside in mouse and beagle dog.
    Moore DJ; Powis G
    Cancer Chemother Pharmacol; 1986; 16(3):218-22. PubMed ID: 3698162
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Influence of high intravenous doses of D-penicillamine on toxic actions of cardiac glycosides in the guinea pig. Short communication (author's transl)].
    Neugebauer G
    Arzneimittelforschung; 1977; 27(11):2073-4. PubMed ID: 580003
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics and metabolism of omeprazole in animals and man--an overview.
    Regårdh CG; Gabrielsson M; Hoffman KJ; Löfberg I; Skånberg I
    Scand J Gastroenterol Suppl; 1985; 108():79-94. PubMed ID: 3858978
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics of teicoplanin in man after intravenous administration.
    Traina GL; Bonati M
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):119-28. PubMed ID: 6238156
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variability of fentanyl pharmacokinetics in man. Computer predicted plasma concentrations for three intravenous dosage regimens.
    Reilly CS; Wood AJ; Wood M
    Anaesthesia; 1985 Sep; 40(9):837-43. PubMed ID: 4051149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
    Sponer G; Kühnle HF; Strein K; Bartsch W; Endele R; Dietmann K
    J Pharmacol Exp Ther; 1984 Jan; 228(1):235-9. PubMed ID: 6694105
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The pharmacokinetics of digoxin in newborn and adult sheep.
    Berman W; Musselman J; Shortencarrier R
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):173-86. PubMed ID: 7120047
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical tolerance and toxicity of intravenous baclofen: a pilot study in a canine model.
    Krach LE; Kriel RL; Patterson EE; Scherkenbach LA; Coles LD; Cloyd JC
    J Pediatr Rehabil Med; 2011; 4(2):89-98. PubMed ID: 21955965
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics of clonazepam in the dog.
    Al-Tahan F; Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):180-93. PubMed ID: 6732363
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urinary excretion of metals during treatment with D-penicillamine and 2-mercaptopropionylglycine in normal and cystinuric dogs.
    Hoppe A; Denneberg T; Frank A; Kågedals B; Petersson LR
    J Vet Pharmacol Ther; 1993 Mar; 16(1):93-102. PubMed ID: 8479006
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cimetidine interaction with dipotassium clorazepate disposition in the anesthetized dog.
    Colin P; Sirois G; Lelorier J
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):12-24. PubMed ID: 6145392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
    Yancey MF; Merritt DA; Lesman SP; Boucher JF; Michels GM
    J Vet Pharmacol Ther; 2010 Apr; 33(2):162-71. PubMed ID: 20444041
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.
    Teramura T; Watanabe T; Higuchi S; Hashimoto K
    Xenobiotica; 1995 Nov; 25(11):1237-46. PubMed ID: 8592872
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The pharmacokinetics of baclofen derived from intestinal infusion.
    Kochak GM; Rakhit A; Wagner WE; Honc F; Waldes L; Kershaw RA
    Clin Pharmacol Ther; 1985 Sep; 38(3):251-7. PubMed ID: 4028618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.